About: Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The present paper is focused on zinc(II) treatment effects on prostatic cell lines PC-3 (tumour) and PNT1A (non-tumour). Oxidative status of cells was monitored by evaluation of expression of metallothionein (MT) isoforms 1A and 2A at the mRNA and protein level, glutathione (oxidised and reduced), and intracellular zinc(II) after exposition to zinc(II) treatment at concentrations of 0-150 mu M using electrochemical methods, western blotting and fluorescent microscopy. A novel real-time impedance-based growth monitoring system was compared with widely used end-point MTT assay. Impedance-based IC50 for zinc(II) is 55.5 and 150.8 mu M for PC-3 and PNT1A, respectively. MTT-determined IC50 are } 1.3-fold higher. Impedance-based viability correlates with viable count (r } 0.92; p { 0.03), not with MTT. Two-fold lower intracellular zinc(II) in the tumour PC-3 cell line was found. After zinc(II) treatment } 2.6-fold increase of intracellular zinc(II) was observed in non-tumour PNT1A and in tumour PC-3 cells. In PC-3 cells, free and bound zinc(II) levels were enhanced more markedly as compared to PNT1A. PNT1A produced 4.2-fold less MT compared to PC3. PNT1A cells showed a 4.8-fold increase trend (r = 0.94; p = 0.005); PC-3 did show a significant trend at MT1 and MT2 protein levels (r = 0.93; p = 0.02) with nearly ten-fold increase after 100 mu M zinc(II) treatment.
  • The present paper is focused on zinc(II) treatment effects on prostatic cell lines PC-3 (tumour) and PNT1A (non-tumour). Oxidative status of cells was monitored by evaluation of expression of metallothionein (MT) isoforms 1A and 2A at the mRNA and protein level, glutathione (oxidised and reduced), and intracellular zinc(II) after exposition to zinc(II) treatment at concentrations of 0-150 mu M using electrochemical methods, western blotting and fluorescent microscopy. A novel real-time impedance-based growth monitoring system was compared with widely used end-point MTT assay. Impedance-based IC50 for zinc(II) is 55.5 and 150.8 mu M for PC-3 and PNT1A, respectively. MTT-determined IC50 are } 1.3-fold higher. Impedance-based viability correlates with viable count (r } 0.92; p { 0.03), not with MTT. Two-fold lower intracellular zinc(II) in the tumour PC-3 cell line was found. After zinc(II) treatment } 2.6-fold increase of intracellular zinc(II) was observed in non-tumour PNT1A and in tumour PC-3 cells. In PC-3 cells, free and bound zinc(II) levels were enhanced more markedly as compared to PNT1A. PNT1A produced 4.2-fold less MT compared to PC3. PNT1A cells showed a 4.8-fold increase trend (r = 0.94; p = 0.005); PC-3 did show a significant trend at MT1 and MT2 protein levels (r = 0.93; p = 0.02) with nearly ten-fold increase after 100 mu M zinc(II) treatment. (en)
Title
  • Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining
  • Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining (en)
skos:prefLabel
  • Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining
  • Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining (en)
skos:notation
  • RIV/62157124:16370/12:43871328!RIV13-MSM-16370___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(ED1.1.00/02.0068), P(GAP102/11/1068), P(GP301/09/P436), S
http://linked.open...iv/cisloPeriodika
  • 6
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 151678
http://linked.open...ai/riv/idVysledku
  • RIV/62157124:16370/12:43871328
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • glutathione; transporter; differentiation; metallothionein; zinc; acridine-orange; carcinoma-cells; liquid-chromatography; cancer cells; oxidative stress (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [D70058AC1C06]
http://linked.open...i/riv/nazevZdroje
  • Integrative Biology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 4
http://linked.open...iv/tvurceVysledku
  • Adam, Vojtěch
  • Babula, Petr
  • Gumulec, Jaromír
  • Kizek, René
  • Křížková, Soňa
  • Masařík, Michal
  • Sochor, Jiří
  • Sztalmachová, Markéta
  • Zítka, Ondřej
  • Cernei, Natalia
  • Hlavna, Marian
  • Raudenská, Martina
  • Pavkova-Goldbergová, Monika
  • Ruttkay-Nedecky, Branislav
http://linked.open...ain/vavai/riv/wos
  • 000304487300010
issn
  • 1757-9694
number of pages
http://bibframe.org/vocab/doi
  • 10.1039/c2ib00157h
http://localhost/t...ganizacniJednotka
  • 16370
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 38 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software